Abstract:Taï Forest virus (TAFV) is a negative-sense RNA virus in the Filoviridae family. TAFV has caused only a single human infection, but several disease outbreaks in chimpanzees have been linked to this virus. Limited research has been done on this human-pathogenic virus. We sought to establish an animal model to assess TAFV disease progression and pathogenicity at our facility. We had access to two different viral stock preparations from different institutions, both originating from the single human case. Type I interferon receptor knockout mice were inoculated with TAFV stock 1 or stock 2 by the intraperitoneal route. Inoculation resulted in 100% survival with no disease regardless of viral stock preparation or infectious dose. Next, cynomolgus macaques were inoculated with TAFV stock 1 or stock 2. Inoculation with TAFV stock 1 resulted in 100% survival and robust TAFV glycoprotein-specific IgG responses including neutralizing antibodies. In contrast, macaques infected with TAFV stock 2 developed disease and were euthanized 8–11 days after infection exhibiting viremia, thrombocytopenia, and increased inflammatory mediators identified by transcriptional analysis. Histopathologic analysis of tissue samples collected at necropsy confirmed classic filovirus disease in numerous organs. Genomic differences in both stock preparations were mapped to several viral genes which may have contributed to disease severity. Taken together, we demonstrate that infection with the two TAFV stocks resulted in no disease in mice and opposing disease phenotypes in cynomolgus macaques, highlighting the impact of viral stock propagation on pathogenicity in animal models. The 2014–2016 West Africa Ebola virus epidemic was the largest in history affecting 10 countries globally, highlighting concerns for future filovirus outbreaks. In contrast, Taï Forest virus (TAFV), another filovirus, has caused a single human case of infection originating from a TAFV disease outbreak in chimpanzees in West Africa which demonstrates transmission to humans. However, limited research has been performed on this human pathogen. We wanted to fill this knowledge gap and characterize disease as more filovirus outbreaks occur in West Africa. We had access to two TAFV stock preparations with sequence differences from separate institutions, both originating from the single human case. The impact of sequence differences on TAFV pathogenicity was assessed cohorts of mice and macaques by infection with either TAFV stock. While both stocks caused no disease in mice, macaques displayed opposing disease phenotypes. Infection with TAFV stock 1 resulted in 100% survival with minimal disease; in contrast, macaques infected with TAFV stock 2 developed fatal disease within 11 days. Genomic differences between stock preparations were associated with viral entry and genome replication which could contribute to disease severity. This study highlights the importance of viral genomic differences and their impact on viral pathogenicity.

Comparative pathogenesis of three Mayaro virus genotypes in the cynomolgus macaque

Mayaro virus pathogenesis and immunity in rhesus macaques

Exposure Route Influences Disease Severity in the COVID-19 Cynomolgus Macaque Model

Effects of Chikungunya virus immunity on Mayaro virus disease and epidemic potential

Development of a Well-Characterized Cynomolgus Macaque Model of Marburg Virus Disease for Support of Vaccine and Therapy Development

Experimental SSM-CVB3 Infection in Macaques

Animal model of arthritis and myositis induced by the Mayaro virus

Characterization of the Cynomolgus Macaque Model of Marburg Virus Disease and Assessment of Timing for Therapeutic Treatment Testing

Mayaro virus infection elicits a robust pro-inflammatory and antiviral response in human macrophages

Pathogenic differences of cynomolgus macaques after Taï Forest virus infection depend on the viral stock propagation

Comparison of SARS-CoV-2 infections among 3 species of non-human primates

Comparison of SARS-CoV-2 Infections Among Three Species of Non-Human Primates

Mayaro Virus: An Emerging Alphavirus in the Americas

Essential role of the CCL2–CCR2 axis in Mayaro virus-induced disease

Establishment of a Rhesus Macaque Model for Coxsackievirus A6 Infection: Pilot Study to Evaluate Infection Initiated Through the Respiratory or Digestive Track

Cross-Species Rhesus Cytomegalovirus Infection of Cynomolgus Macaques

Efficacy and Immunogenicity of a Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine in Cynomolgus Macaques

Characterization of Systemic Disease Development and Paw Inflammation in a Susceptible Mouse Model of Mayaro Virus Infection and Validation Using X-ray Synchrotron Microtomography

Nonreciprocity in CHIKV and MAYV Vaccine-Elicited Protection

Viral Kinetics Are Associated with Changes in Cytokines and Chemokines in Serum and Target Organs of SSM-CVB3-infected Macaques.

Effect of Oral Infection of Mayaro Virus on Fitness Correlates and Expression of Immune Related Genes in Aedes aegypti